0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Optic Nerve Decompression Surgery for Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) Is Not Effective and May Be Harmful

Kay Dickersin, PhD; Donald Everett, MA; Steven Feldon, MD; Frank Hooper, ScD; David Kaufman, DO; Shalom Kelman, MD; Patricia Langenberg, PhD; Nancy J. Newman, MD; P. David Wilson, PhD; Z. Suzanne Zam; John Kennerdell, MD; Anna Tyutyunikov, MD; Russell Edwards, MD; Todd Goodglick, MD; Deborah Lang; Kimberly Peele, MD; Sophia Chung, MD; Diana Mekelburg, COT; John Holds, MD; John Selhorst, MD; Mark Malton, MD; Sonia Armstrong, COT; Yvonne McCracken, MPH; Eugene Benjamin, MD; Carol Dellinger; Traci Hunter Medlin, COT; Barbara Kinsler; Mike McOwen, CLP; Donna Russell, COT; Timothy Saunders, MD; Gregory Kosmorsky, DO; Tina Kiss; Cate Reinhard; Laura De Venne; Janet Edgerton; Tami Fecko; Susannah Hanson; Brian Kraus; Deborah Ross; Nancy Tomsak; Pamela Vargo; Rufus Willis; Kerry Zimmerman, MS; Kristin Anderson, COMT; Richard Cortez; Karen DeBlanc, COA; Judy Hulse, COT; Ronald B. Morales; Tracy Nichols, CRA; Lillian Reyes, COT; Nadine Rodarte-Ochoa, COT; Daniel Romo; Alfredo Sadun, MD; Mary Steber, COMT; Frances Walonker, COMT; Donna Loupe, BA; Diana Coffman, MMSc; Harvey Cole III, MD; Ted Wojno, MD; Barry Skarf, MD; Colleen Wojtala; Mark Croswell; Wendy Gilroy; Christian Mageli; Dena McDonald; George Ponka; Rosa Tang, MD; Melissa Hamlin; Jewel Curtis; Jay Forman; Kenneth Hyde, MD; Kirk Mack; Portia Tello; Anthony Arnold, MD; Berniee Cibener, BA; Melody Acero; Bobbi Ballenberg, COMT; Anne Bolton; Robert Goldberg, MD; Lynn Gordon, MD; Michael Heneghan; Howard Krauss, MD; Jackie Sanguinei; Robert Stalling; Jenja Yadegaran, BS; Wayne Cornblath, MD; Barbara Michael; Donna Campbell, COT; Cheryl Caudill, COT; Christine Nelson, MD; Jonathan Trobe, MD; Lenworth N. Johnson, MD; Gaye Baker; Coy Cobb, CRA, COT; Philip Custer, MD; Sharon Turner, COA; Roy Wilson, MS, COMT; Brian Younge, MD; Jacqueline Leavitt, MD; Rebecca Nielsen, LPN; Jody Allen; Barbara Eickhoff, COT; James Garrity, MD; Jacqueline Ladsten; Kathleen LeBarron, COA; Thomas P. Link, BA; Jay Rostvold; Karen Weber; Warren Felton III, MD; Tracy Boney, AS; Danielle Gabriel, BS; Daniel David, MS; Lahn Fendelander, MS; Daniel Geller, MD; Timothy Jordan, MD; Christian Kim, MD; Craig Munger, MD; Jo Anne Romandy, COA; George Sanborn, MD; Bradley Schwartz, MD; Carl Sheusi, BA; Constance Smith, MD; Kathy Talley, AS; Sandya Thimmappa, BS; Eric Eggenberger, DO; Suzanne Bickert, RN; Robert Granadier, MD; Sandra Holliday; Thomas Moore, MD; Jaya Varadarajan, MD; Deborah Friedman, MD; Patricia Jones, LPN, COT; Haris Amin, MD; Thomas Bersani, MD; Cynthia Briglin, MD; James Fooks; Michael Graham, MD; Milton James, MD; Gary Michalec; Hoang Nguyen; Jonathan Horton, MD; Maeve Chang, BA; Lou Anne Aber, COA; Erik Lindstrom, COMT; Stuart Seiff, MD; John Guy, MD; Z. Suzanne Zam, BS; Amye Francis, CO; Latif Hamed, MD; Alan Lessner, MD; Donna McDavid, COMT; Diana Shamis, MHSE; James Goodwin, MD; Martin E. Lindeman, COMT; Allen Putterman, MD; Phyllis Bobak, PhD; Robert Baker, MD; Judy Beck; David Cowen, MD; Avrom Epstein, MD; Michael Hanson; Toni Scoggins, COA; Ann M. Rodavitch, MA; Brenda Gore; Andrea Blake, MA; Michele Heroux, CRA; Rani Kalsi; Charlene Krauch, COMT; Mary Ann Millar, COMT; Mitchell Wolin, MD; Rita Jean Brady, COA; Regina Hansen, COA; Michael Briggs; Karkarla V. Chalam, MD; Barbara Danner; Beverly Simons, COT; Anne Stewart, CO; Kathleen Digre, MD; Lizbeth Malmquist-Webb; Terrell Blackburn; Susan Baggaley; Richard Anderson, MD; Charles Juarez; Bonnie Kaye; Paul Langer, MD; Aditya Mishra, MD; Paula Morris; Sandra Osborn; Bhupendra Patel, MD; Tessie Priskos; Sandra Staker; Judith Warner, MD; Steven Newman, MD; Christine Evans, COT; Allison Aylor, COT; Carolyn Childress, COA; Helen Dickerson, RN; Jane Fleming, BA; Nomine Harris, BA; L. Sharon Hoyle, COMT; Ellen Murphy, COT; James Scott, RBP; Karen Summerville, COMT; Mariann Terrell, CO; Lillian Tyler, COA; John Linberg, MD; Lenore Breen, MD; Michelle Michael, COT; Charlene Campbell, COT; Brian Ellis, MD; Nancy Groves, COA; Robert Hobson; Gordon McGregor; Laura Shepherd, COA; Edward Cohn, MD; Patricia Manatrey; Sara Casey; John Johnson; Coletti Kronner; Virginia Regan; Patricia Streasick; Michael Elman, MD; Aim M. Rodavitch, MA; Roberta Scherer, PhD; Barbara Crawley, MS; Cheryl Hiner; Lucy Howard; Olga Lurye; Robert McCarter, ScD; Sara Riedel; Michelle Sotos; Laureen Spioch; Joann Starr; Judy Urban; Mark Waring; Danielle Gabriel; Stuart R. Seiff, MD
JAMA. 1995;273(8):625-632. doi:10.1001/jama.1995.03520320035038.
Text Size: A A A
Published online

Objective.  —To assess the safety and efficacy of optic nerve decompression surgery compared with careful follow-up alone in patients with nonarteritic anterior ischemic optic neuropathy (NAION).

Design.  —The Ischemic Optic Neuropathy Decompression Trial (IONDT) is a randomized, single-masked, multicenter trial.

Setting.  —Twenty-five US clinical centers.

Participants.  —The IONDT ceased recruitment on October 20, 1994, on the recommendation of its Data and Safety Monitoring Committee. The preliminary results presented herein are based on data as of September 8,1994, from 244 patients with NAION and visual acuity of 20/64 or worse. One hundred twenty-five patients had been randomized to careful follow-up, and 119 had been randomized to surgery, with 91 and 95, respectively, having completed 6 months of follow-up.

Intervention.  —Patients in the surgery group received optic nerve decompression surgery and follow-up ophthalmologic examinations; those in the careful follow-up group received ophthalmologic examinations at the same times as the surgery group.

Main Outcome Measures.  —Gain or loss of three or more lines of visual acuity on the New York Lighthouse chart at 6 months after randomization, as measured by a technician masked to treatment assignment.

Results.  —Patients assigned to surgery did no better when compared with patients assigned to careful follow-up regarding improved visual acuity of three or more lines at 6 months: 32.6% of the surgery group improved compared with 42.7% of the careful follow-up group. The odds ratio (OR) for three or more lines better, adjusted for baseline visual acuity and diabetes, was 0.74 (95% confidence interval [CI], 0.39 to 1.38). Patients receiving surgery had a significantly greater risk of losing three or more lines of vision at 6 months: 23.9% in the surgery group worsened compared with 12.4% in the careful follow-up group. The 6-month adjusted OR for three or more lines worse was 1.96 (95% CI, 0.87 to 4.41). No difference in treatment effect was observed between patients with progressive NAION and all others.

Conclusion.  —Results from the IONDT indicate that optic nerve decompression surgery for NAION is not effective, may be harmful, and should be abandoned. The spontaneous improvement rate is better than previously reported.(JAMA. 1995;273:625-632)

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();